Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Homology Medicines Inc (FIXX)
NASDAQ:FIXX
RESEARCH TOOLSreports
Holding FIXX?
Track your performance easily
FIXX Stock Chart & Stats
Day’s Range$0.9 - $0.97
52-Week Range― - ―
Previous Close$0.93
Volume401.47K
Average Volume (3M)N/A
Market Cap
$52.22M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FIXX FAQ
What was Homology Medicines Inc’s price range in the past 12 months?
Currently, no data Available
What is Homology Medicines Inc’s market cap?
Currently, no data Available
When is Homology Medicines Inc’s upcoming earnings report date?
Homology Medicines Inc’s upcoming earnings report date is May 13, 2024 which is 181 days ago.
How were Homology Medicines Inc’s earnings last quarter?
Homology Medicines Inc released its earnings results on Mar 13, 2024. The company reported -$5.001 earnings per share for the quarter, beating the consensus estimate of -$5.4 by $0.399.
Is Homology Medicines Inc overvalued?
According to Wall Street analysts Homology Medicines Inc’s price is currently Overvalued.
Does Homology Medicines Inc pay dividends?
Homology Medicines Inc does not currently pay dividends.
What is Homology Medicines Inc’s EPS estimate?
Homology Medicines Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Homology Medicines Inc have?
Currently, no data Available
What happened to Homology Medicines Inc’s price movement after its last earnings report?
Homology Medicines Inc reported an EPS of -$5.001 in its last earnings report, beating expectations of -$5.4. Following the earnings report the stock price went up 1.424%.
Which hedge fund is a major shareholder of Homology Medicines Inc?
Among the largest hedge funds holding Homology Medicines Inc’s share is Western Standard Llc. It holds Homology Medicines Inc’s shares valued at N/A.
---
Homology Medicines Stock Smart Score
Company Description
Homology Medicines Inc
Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.
---
FIXX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering FIXX
1 Year
1 Year Success Rate
0/9 ratings generated profit
1 Year Average Return
-40.42%
reiterated a buy rating 2 years ago
Copying Michelle Gilson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.42% per trade.
---